Bone marrow niches in haematological malignancies

S Méndez-Ferrer, D Bonnet, DP Steensma… - Nature Reviews …, 2020 - nature.com
Haematological malignancies were previously thought to be driven solely by genetic or
epigenetic lesions within haematopoietic cells. However, the niches that maintain and …

Adult haematopoietic stem cell niches

GM Crane, E Jeffery, SJ Morrison - Nature Reviews Immunology, 2017 - nature.com
Stem cell niches are specialized microenvironments that promote the maintenance of stem
cells and regulate their function. Recent advances have improved our understanding of the …

Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

A Aguayo, H Kantarjian, T Manshouri… - Blood, The Journal …, 2000 - ashpublications.org
Angiogenesis has been associated with the growth, dissemination, and metastasis of solid
tumors. The aims of this study were to evaluate the vascularity and the levels of angiogenic …

Myeloid malignancies and the microenvironment

C Korn, S Méndez-Ferrer - Blood, The Journal of the American …, 2017 - ashpublications.org
Research in the last few years has revealed a sophisticated interaction network between
multiple bone marrow cells that regulate different hematopoietic stem cell (HSC) properties …

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

K Podar, KC Anderson - Blood, 2005 - ashpublications.org
Besides its role as an essential regulator of physiologic and pathologic angiogenesis,
vascular endothelial growth factor (VEGF) triggers growth, survival, and migration of …

Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells

N Quirici, D Soligo, L Caneva, F Servida… - British journal of …, 2001 - Wiley Online Library
We report a method of purifying, characterizing and expanding endothelial cells (ECs)
derived from CD133+ bone marrow cells, a subset of CD34+ haematopoietic progenitors …

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

P Mancuso, A Burlini, G Pruneri… - Blood, The Journal …, 2001 - ashpublications.org
Circulating endothelial cells (CECs) were enumerated in 20 healthy controls and 76 newly
diagnosed cancer patients by means of 4-color flow cytometry. In breast cancer (n= 46) and …

Vascular endothelial growth factor (VEGF)–C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

S Dias, M Choy, K Alitalo, S Rafii - Blood, The Journal of the …, 2002 - ashpublications.org
Similar to solid tumors, growth of leukemias may also be angiogenesis dependent.
Furthermore, tyrosine kinase receptors specific to endothelial cells are expressed on certain …

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in …

WT Bellamy, L Richter, D Sirjani… - Blood, The Journal …, 2001 - ashpublications.org
Vascular endothelial growth factor (VEGF) is a potent angiogenic peptide with biologic
effects that include regulation of hematopoietic stem cell development, extracellular matrix …

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes

A Raza, P Meyer, D Dutt, F Zorat, L Lisak… - Blood, The Journal …, 2001 - ashpublications.org
Thalidomide was administered to 83 patients with myelodysplastic syndrome (MDS), starting
at 100 mg by mouth daily and increasing to 400 mg as tolerated. Thirty-two patients stopped …